- |||||||||| ivermectin / Generic mfg., budesonide / Generic mfg., nitazoxanide / Generic mfg.
Clinical: Big pharma It’s pushing the expensive options first, with evidence of futility . half mill people die. secure, cheap and effective options most be studied first in masive multicentric internacional trials . Ivermectin, Nitazoxanide, Melatonin,Vit D,C, B1, Zinc, Budesonide. (Twitter) - Aug 7, 2020
- |||||||||| budesonide / Generic mfg.
Journal: Esophageal lichen planus: towards diagnosis of an underdiagnosed disease. (Pubmed Central) - Aug 5, 2020 Follow-up of 14/16 patients with severe EPL for at least one year revealed that most of these patients responded to topical corticosteroids (budesonide: n = 9/10 or fluticasone n = 2/2)...Dysphagia and combined oral and genital manifestation are associated with ELP. Therapy with topical corticosteroids appears to be a prudent therapeutic approach for ELP.
- |||||||||| budesonide / Generic mfg.
[VIRTUAL] Diagnosis and treatment of eosinophilic esophagitis (p.606) - Aug 2, 2020 - Abstract #WAC2020WAC_214; For this reason, fluticasone and budesonide are used in cases of gastric acid secretion inhibitor resistance...Furthermore, recently, treatment with antibody preparations against IL-5, IL-13 and its receptor has been performed. Treatment has also begun.
- |||||||||| budesonide / Generic mfg., methotrexate / Generic mfg., budesonide ER / Generic mfg.
Review, Journal: Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations. (Pubmed Central) - Aug 1, 2020 Immunomodulating drugs, such as thiopurines and methotrexate, should be continued, without modifying doses (even in patients with positive SARS-CoV-2 infection)...Budesonide MMX should be considered in cases of mild-to-moderate activity, to avoid systemic steroid use...Finally, biologic treatment with anti-TNF-alpha agents or any other mechanism of action, such as anti-integrins or anti-interleukins, should be suspended if patients become infected with SARS-CoV-2. The drugs can be restarted once the infectious process is resolved.
- |||||||||| budesonide / Generic mfg., Budenofalk (budesonide effervescent tablet) / Dr Falk
Journal: EMERGING THERAPIES FOR EOSINOPHILIC ESOPHAGITIS. (Pubmed Central) - Jul 29, 2020 Finally, further insights into the pathogenesis of EoE have revealed several novel disease mediators that might be targeted in the future. In the following article, we will discuss recent advances in EoE treatment with regards to swallowed topical steroids, biological agents, dietary approaches and novel molecular targets.
- |||||||||| Lacromid (bezafibrate) / Remedica, Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Review, Journal: Current and potential treatments for primary biliary cholangitis. (Pubmed Central) - Jul 29, 2020 Bezafibrate, a pan-peroxisome proliferator-activated receptor agonist, has been shown to ameliorate deranged bile acid homoeostasis and attenuate raised concentrations of liver enzymes associated with primary biliary cholangitis...Various therapeutic target bile acid homeostasis, immune dysfunction, and fibrogenetic pathways are being studied. A better understanding of the biochemical and clinical effects of the therapies in development bear discussion, both to guide the discovery of new therapies and to inform clinicians so that rational treatment regimens can be tailored to patients once they become available.
- |||||||||| budesonide / Generic mfg.
Clinical, Review, Journal: Inhaled Corticosteroids as an Associated Risk Factor for Asthmatic Pneumonia: A Literature Review. (Pubmed Central) - Jul 24, 2020 In observational studies that excluded COPD patients and in randomized controlled trials, ICS use was not found to be associated with the risk of pneumonia. Hence, COPD patients should be excluded in future studies, and the currently available evidence demonstrates that ICS use is not associated with an increased risk of pneumonia in asthma patients.
- |||||||||| budesonide / Generic mfg.
Review, Journal: Eosinophilic esophagitis: An evidenced-based approach to diagnosis and treatment. (Pubmed Central) - Jul 19, 2020 Topical glucocorticosteroids budesonide and fluticasone reduce eosinophilic inflammation and reverse symptoms. This review includes the most relevant aspects of the epidemiology, diagnosis, treatment and monitoring of eosinophilic oesophagitis.
- |||||||||| sertraline / Generic mfg.
[VIRTUAL] A RARE CAUSE OF ASCITES IN A YOUNG PATIENT (Poster Exhibition) - Jul 19, 2020 - Abstract #UEGW2020UEGW_5540; Clinical Case Summary: A 18 year-old male with Klinefelter syndrome, medicated with sertraline and testosterone, presented with a 2-month history of nausea, intermittent abdominal pain and diarrhea...The patient was treated with pantoprazole 40 mg twice a day and budesonide 9 mg a day...The signs and symptoms are related to the location, extent, and layers involved. Our patient presented with abdominal pain, ascites and pleural effusion, associated with the involvement of mucosa and serosa layers of the stomach.
|